🎉 Up to 70% Off Selected ItemsShop Sale
HomeStore

Seretide Metered Dose Inhaler 125/25 mcg - Fluticasone Propionate

Product image 1

Seretide Metered Dose Inhaler 125/25 mcg - Fluticasone Propionate

Seretide Metered Dose Inhaler 125/25 mcg

Introducing the Seretide Metered Dose Inhaler, a reliable solution for managing asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines Fluticasone Propionate and Salmeterol Xinafoate to provide effective relief and control of respiratory symptoms.

Key Features
  • Combination of Fluticasone Propionate and Salmeterol Xinafoate
  • Designed for regular use to maintain optimal respiratory function
  • Suitable for adults and adolescents aged 12 years and older
Technical Specifications
  • Fluticasone Propionate 125 mcg
  • Salmeterol Xinafoate 25 mcg
  • Form Metered Dose Inhaler
Application

Ideal for individuals with asthma or COPD requiring regular maintenance therapy.

Typical User Profile

Adults and adolescents aged 12 years and older with respiratory conditions.

About the Brand

GlaxoSmithKline is a leader in respiratory health, known for pioneering innovative treatments and therapies to improve patient outcomes.

$35.75
Seretide Metered Dose Inhaler 125/25 mcg - Fluticasone Propionate—
$35.75

Product Information

Shipping & Returns

Description

Seretide Metered Dose Inhaler 125/25 mcg

Introducing the Seretide Metered Dose Inhaler, a reliable solution for managing asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines Fluticasone Propionate and Salmeterol Xinafoate to provide effective relief and control of respiratory symptoms.

Key Features
  • Combination of Fluticasone Propionate and Salmeterol Xinafoate
  • Designed for regular use to maintain optimal respiratory function
  • Suitable for adults and adolescents aged 12 years and older
Technical Specifications
  • Fluticasone Propionate 125 mcg
  • Salmeterol Xinafoate 25 mcg
  • Form Metered Dose Inhaler
Application

Ideal for individuals with asthma or COPD requiring regular maintenance therapy.

Typical User Profile

Adults and adolescents aged 12 years and older with respiratory conditions.

About the Brand

GlaxoSmithKline is a leader in respiratory health, known for pioneering innovative treatments and therapies to improve patient outcomes.